Gina Mauro | Authors


AMG 757 Elicits Early Response, Safety in Small Cell Lung Cancer

June 18, 2021

First-in-human results of a phase 1 trial (NCT03319940) evaluating AMG 757 in patients with small cell lung cancer revealed early signals of efficacy and a favorable safety profile in findings presented at the European Lung Cancer Virtual Congress 2021.